DOSSIER · 13F-HR · Q2 2026

Bleichroeder LP

$559M in tracked AUM across 78 positions as of Q2 2026.

BL
CIK 0001781002 · last filed Jun 30, 2026
Total AUM
$559M
as of Q2 2026
Holdings
78
positions
Whale Score
66
66
tracked
Activity
no data
changes this Q
AI Analysis · Q2 2026
Comprehensive Analysis of Bleichroeder LP SEC 13F Filing (Q3 2025)
1. Portfolio Overview

Bleichroeder LP manages a concentrated portfolio valued at approximately $481.21 million as of September 30, 2025, representing a robust growth of 18.3% from the previous quarter's $406.80 million. The portfolio consists of 52 holdings, indicating a strategy that balances significant core positions with a broad tail of smaller, speculative investments.

The fund demonstrates a "Barbell" inv...

2. Key Holdings

The portfolio is heavily top-heavy, with the top three positions accounting for 60.16% of the total assets under management (AUM).

  • SPDR Gold Trust (GLD): This is the dominant position, comprising 35.09% ($168.85M) of the portfolio. This massive allocation to gold suggests a strong defensive or inflation-hedge bias. It serves as the portfolio's anchor, providing stability against the volatility observed in the smaller equity positions.
  • Composecure Inc (CMPO): The second-largest holding at 16.96% ($81.60M). This represents a significant conviction bet on the financial services/technology infrastructure sector. The large stake size relative to the company's market cap implies the fund may have significant influence or a deep fundamental thesis regarding the company's growth.
  • Linde PLC (LIN): A defensive industrial giant holding 8.11% ($39.00M). This provides the portfolio with exposure to high-quality industrial earnings and diversification away from the high-volatility micro-caps that populate the rest of the list.
  • MDxHealth SA: Represents 7.13% ($34.31M), reinforcing the fund's interest in the healthcare diagnostics space.
Analysis generated by 13F Insight from SEC Form 13F filing data · Q2 2026. Methodology

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
GLD
SPDR GOLD TR
$175M475K31.3%
02
CMPO
GPGI INC
$63M4.0M11.3%
03
SPY
STATE STR SPDR S&P 500 ETF T
$51M68K9.0%
04
RHLD
RESOLUTE HLDGS MGMT INC
$45M314K8.1%
05
G54950103
LINDE PLC
$31M60K5.6%
06
DUOT
DUOS TECHNOLOGIES GROUP INC
$20M1.6M3.5%
07
DTIL
PRECISION BIOSCIENCES INC
$16M2.0M2.8%
08
CUE
CUE BIOPHARMA INC
$12M371K2.1%
09
BX
BLACKSTONE INC
$11M91K1.9%
10
IMMX
IMMIX BIOPHARMA INC
$10M1.0M1.8%

Filing history

2026Q2Jun 30
$559M 3.4%
78 positionsView →
2026Q1Mar 31
$579M 1.8%
81 positionsView →
2025Q4Dec 31
$568M 18.1%
73 positionsView →
2025Q3Sep 30
$481M 18.3%
52 positionsView →
2025Q2Jun 30
$407M 23.1%
76 positionsLocked
2025Q1Mar 31
$330M 17.0%
56 positionsLocked
2024Q4Dec 31
$398M 7.1%
74 positionsLocked
2024Q3Sep 30
$372M 10.5%
73 positionsLocked
2024Q2Jun 30
$336M 16.1%
75 positionsLocked
2024Q1Mar 31
$401M 10.9%
80 positionsLocked
2023Q4Dec 31
$450M 10.9%
77 positionsLocked
2023Q3Sep 30
$406M 17.7%
74 positionsLocked
Showing 12 of 27